thiazoles has been researched along with Leishmaniasis, American in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Amorim, CF; Beiting, D; Carvalho, AM; Carvalho, EM; Carvalho, LP; Franca, M; Nascimento, MT; Peixoto, F; Scott, P | 1 |
Akhoundi, B; Ebrahimzade, E; Elikaee, S; Khalili, S; Mohammadi-Yeganeh, S; Mohebali, M; Moosazadeh Moghaddam, M; Sharifi-Yazdi, MK; Shayan, P | 1 |
Grace, E; Gurgen, J; Hogan, D; Johnson, D | 1 |
3 other study(ies) available for thiazoles and Leishmaniasis, American
Article | Year |
---|---|
Inhibition of gamma-secretase activity without interfering in Notch signalling decreases inflammatory response in patients with cutaneous leishmaniasis.
Topics: Amyloid Precursor Protein Secretases; Antigens, Protozoan; Cells, Cultured; Cross-Sectional Studies; Cytokines; Diamines; Humans; Inflammation; Leishmania braziliensis; Leishmaniasis, Cutaneous; Monocytes; Protease Inhibitors; Receptor, Notch1; Receptors, Notch; Signal Transduction; Thiazoles | 2021 |
Investigation of the antimicrobial activity of a short cationic peptide against promastigote and amastigote forms of Leishmania major (MHRO/IR/75/ER): An in vitro study.
Topics: Animals; Antimicrobial Cationic Peptides; Antiprotozoal Agents; Coloring Agents; DNA, Protozoan; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine Antimoniate; Mice; RAW 264.7 Cells; Real-Time Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Trypan Blue | 2019 |
Nitazoxanide in the treatment of chronic cutaneous leishmaniasis resistant to traditional sodium stibogluconate.
Topics: Administration, Oral; Antimony Sodium Gluconate; Antiparasitic Agents; Biopsy, Needle; Drug Administration Schedule; Drug Resistance; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Leishmaniasis, Cutaneous; Male; Nitro Compounds; Retreatment; Severity of Illness Index; Thiazoles; Treatment Outcome; Young Adult | 2011 |